IBDEI3CK ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,56232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56232,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbances,Unspec
 ;;^UTILITY(U,$J,358.3,56232,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,56232,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,56233,0)
 ;;=G31.83^^256^2795^14
 ;;^UTILITY(U,$J,358.3,56233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56233,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,56233,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,56233,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,56234,0)
 ;;=F01.51^^256^2795^30
 ;;^UTILITY(U,$J,358.3,56234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56234,1,3,0)
 ;;=3^Vascular Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,56234,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,56234,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,56235,0)
 ;;=F01.50^^256^2795^31
 ;;^UTILITY(U,$J,358.3,56235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56235,1,3,0)
 ;;=3^Vascular Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,56235,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,56235,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,56236,0)
 ;;=A81.9^^256^2795^6
 ;;^UTILITY(U,$J,358.3,56236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56236,1,3,0)
 ;;=3^Atypical Virus Infection of CNS,Unspec
 ;;^UTILITY(U,$J,358.3,56236,1,4,0)
 ;;=4^A81.9
 ;;^UTILITY(U,$J,358.3,56236,2)
 ;;=^5000414
 ;;^UTILITY(U,$J,358.3,56237,0)
 ;;=A81.09^^256^2795^8
 ;;^UTILITY(U,$J,358.3,56237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56237,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease NEC
 ;;^UTILITY(U,$J,358.3,56237,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,56237,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,56238,0)
 ;;=A81.00^^256^2795^9
 ;;^UTILITY(U,$J,358.3,56238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56238,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,56238,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,56238,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,56239,0)
 ;;=A81.01^^256^2795^10
 ;;^UTILITY(U,$J,358.3,56239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56239,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,56239,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,56239,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,56240,0)
 ;;=A81.89^^256^2795^7
 ;;^UTILITY(U,$J,358.3,56240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56240,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,56240,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,56240,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,56241,0)
 ;;=A81.2^^256^2795^27
 ;;^UTILITY(U,$J,358.3,56241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56241,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,56241,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,56241,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,56242,0)
 ;;=B20.^^256^2795^17
 ;;^UTILITY(U,$J,358.3,56242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56242,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,56242,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,56242,2)
 ;;=^5000555^F02.81
 ;;^UTILITY(U,$J,358.3,56243,0)
 ;;=B20.^^256^2795^18
 ;;^UTILITY(U,$J,358.3,56243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56243,1,3,0)
 ;;=3^HIV Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,56243,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,56243,2)
 ;;=^5000555^F02.80
 ;;^UTILITY(U,$J,358.3,56244,0)
 ;;=F10.27^^256^2795^1
 ;;^UTILITY(U,$J,358.3,56244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56244,1,3,0)
 ;;=3^Alcohol Dependence w/ Alcohol-Induced Persisting Dementia
 ;;^UTILITY(U,$J,358.3,56244,1,4,0)
 ;;=4^F10.27
